LCG
RXST icon

Lisanti Capital Growth’s RxSight RXST Stock Holding History

Lisanti Capital Growth’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-69,840
Closed -$3.45M – 132
2024
Q3 		$3.45M Sell
69,840
-25,380
-27% -$1.3M 0.87% 50
2024
Q2 		$5.73M Sell
95,220
-1,115
-1% -$63.7K 1.38% 22
2024
Q1 		$4.97M Sell
96,335
-14,485
-13% -$711K 1.21% 30
2023
Q4 		$4.47M Sell
110,820
-12,385
-10% -$363K 1.05% 38
2023
Q3 		$3.44M Buy
123,205
+64,130
+109% +$1.91M 0.54% 76
2023
Q2 		$1.7M Buy
+59,075
New +$1.31M 0.24% 118

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Lisanti Capital Growth's RXST Position: Q4 2024 in Review

Lisanti Capital Growth sold out of RxSight (RXST) in Q4 2024, closing a stake of 69,840 shares — an estimated $3.45M sold.

Lisanti Capital Growth first reported a position in RXST in Q2 2023 and held it in 6 quarters. The position peaked at $5.73M in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Lisanti Capital Growth reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Lisanti Capital Growth sold 69,840 RxSight shares in Q4 2024, an estimated $3.45M.
  • Lisanti Capital Growth first reported a position in RxSight in Q2 2023 and held it in 6 quarters.
  • Lisanti Capital Growth's RxSight position peaked at $5.73M in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Lisanti Capital Growth's 13F filing for Q4 2024, filed 7 Feb 2025.